United Health Products settles SEC probe; FDA PMA meeting moved to July 13

United Health Products, Inc.

Accepted SEC settlement terms; complaint filed June 8, 2022; consent judgment to follow; no terms for individuals Beplate, Schiliro.
FDA Class III PMA meeting rescheduled to July 13 from July 6 at FDA's request.
Settlement terms previously reported in 2021 Annual Report and April 29, 2022 8-K.
No additional FDA requests for information received as of this date on PMA application.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.